Alnylam Pharmaceuticals Aktie
262,10
EUR
-7,60
EUR
-2,82
%
306,60
USD
-5,69
USD
-1,82
%
Werbung
Alnylam Pharmaceuticals Aktie Analyse
| 20.08.08 | Alnylam Pharmaceuticals underperform | Leerink Swann LLC | |
| 03.03.08 | Alnylam Pharmaceuticals underperform | Needham & Company, LLC |
Werbung
Werbung